An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer

Spigel, DR; Luft, A; Depenbrock, H; Ramlau, R; Khalil, M; Kim, JH; Mayo, C; Chao, GY; Obasaju, C; Natale, R

Spigel, DR (reprint author), Sarah Cannon Res Inst, Med Oncol, 250 25th Ave N Ste 110, Nashville, TN 37203 USA.

CLINICAL LUNG CANCER, 2017; 18 (5): 480

Abstract

This open-label, randomized, phase II study was intended to compare paclitaxel-carboplatin with necitumumab versus paclitaxel-carboplatin alone for th......

Full Text Link